Bridging the Gap of Drug Delivery in Colon Cancer: The Role of Chitosan and Pectin Based Nanocarriers System

Author(s): Rohitas Deshmukh*

Journal Name: Current Drug Delivery

Volume 17 , Issue 10 , 2020

Become EABM
Become Reviewer

Graphical Abstract:


Colon cancer is one of the most prevalent diseases, and traditional chemotherapy has not been proven beneficial in its treatment. It ranks second in terms of mortality due to all cancers for all ages. Lack of selectivity and poor biodistribution are the biggest challenges in developing potential therapeutic agents for the treatment of colon cancer. Nanoparticles hold enormous prospects as an effective drug delivery system. The delivery systems employing the use of polymers, such as chitosan and pectin as carrier molecules, ensure the maximum absorption of the drug, reduce unwanted side effects and also offer protection to the therapeutic agent from quick clearance or degradation, thus allowing an increased amount of the drug to reach the target tissue or cells. In this systematic review of published literature, the author aimed to assess the role of chitosan and pectin as polymer-carriers in colon targeted delivery of drugs in colon cancer therapy. This review summarizes the various studies employing the use of chitosan and pectin in colon targeted drug delivery systems.

Keywords: Colon cancer, drug carriers, carbohydrate polymers, drug delivery, chitosan, pectin.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2020
Published on: 29 October, 2020
Page: [911 - 924]
Pages: 14
DOI: 10.2174/1567201817666200717090623
Price: $65

Article Metrics

PDF: 19